Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Frankincense oil contains boswellic acids that inhibit 5-lipoxygenase enzymes, reducing inflammatory leukotriene production. The oil demonstrates immune-enhancing properties by stimulating white blood cell activity and reducing joint inflammation by up to 50%.
Reported Benefits (Provisional)
Origin & History
Frankincense oil is derived from the resin of the Boswellia carterii tree, native to the Arabian Peninsula and parts of Africa. It is produced through steam distillation.
Research Narrative (Provisional)
Studies, including RCTs, have shown that frankincense oil has anti-inflammatory and potential anti-cancer properties, though more research is needed.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
Frankincense oil (Boswellia carterii) is an essential/resin oil and not a dietary nutrient source; it contains negligible macronutrients (calories, protein, fat, carbohydrates near zero in therapeutic doses). Its profile is defined by bioactive terpenoid and resinous compounds: Boswellic acids are the primary actives, comprising 25–35% of the raw resin (not all transferred to steam-distilled essential oil) — key forms include acetyl-11-keto-β-boswellic acid (AKBA, ~5–8% of resin extract), 11-keto-β-boswellic acid (KBA), α-boswellic acid, and β-boswellic acid. The essential oil itself (steam-distilled) contains predominantly monoterpenes and sesquiterpenes: α-pinene (up to 40–65% of volatile fraction), limonene (3–8%), β-pinene (2–5%), myrcene (1–4%), sabinene (1–3%), p-cymene (1–3%), linalool (1–2%), and incensole acetate (~2–5%, neurologically active diterpenoid). Resin extract also contains incensole (~1–3%). Boswellic acids have low oral bioavailability (~1–3% unformulated) but are enhanced with lipid co-administration or piperine. Vitamins and dietary minerals are absent in meaningful quantities. No dietary fiber or protein content. The oil is used topically or aromatically; resin extracts are used supplementally at doses of 300–500 mg standardized to ≥30% boswellic acids.
Reported Mechanism (Provisional)
Frankincense oil's boswellic acids selectively inhibit 5-lipoxygenase (5-LOX) enzymes, preventing the synthesis of pro-inflammatory leukotrienes. The primary compounds AKBA (acetyl-11-keto-β-boswellic acid) and KBA (11-keto-β-boswellic acid) bind directly to the 5-LOX active site. Additionally, boswellic acids modulate NF-κB signaling pathways, reducing inflammatory cytokine production while enhancing T-cell and natural killer cell activity.
Clinical Narrative (Provisional)
Human studies on frankincense extract containing similar boswellic acids show promising anti-inflammatory effects in osteoarthritis patients, with some trials reporting 50-90% improvement in joint function over 8-16 weeks. However, most clinical research focuses on oral Boswellia serrata extracts rather than topical frankincense oil specifically. Limited controlled trials exist for frankincense oil aromatherapy, with small studies (n=20-40) suggesting modest benefits for anxiety and pain perception. More rigorous clinical trials are needed to validate specific dosing and applications for frankincense oil.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.